TY - JOUR
T1 - Immunostaining of mouse atherosclerotic lesions.
AU - Lu, Hong
AU - Rateri, Debra L.
AU - Daugherty, Alan
PY - 2007
Y1 - 2007
N2 - Atherosclerotic lesions develop through interactions with diverse cell types whose functions are determined by a complex array of regulators. Immunostaining is now a commonly applied technique to identify these numerous cell types and regulators in lesions. The principle of the technique is that an antibody is incubated with the tissue under conditions that favor a specific interaction with its antigen. This is subsequently visualized most commonly by a chromogenic substrate that produces a colored precipitate at the location of the antigen-antibody interaction. When appropriately applied, it is a powerful technique to provide mechanistic insight into the atherogenic process. However, the complexity of atherosclerotic tissue can provide challenges to ensuring that development of the chromogen is due to specific antigen-antibody interaction. Thus, the determination of specific interactions frequently requires the judicious use of appropriate control experiments.
AB - Atherosclerotic lesions develop through interactions with diverse cell types whose functions are determined by a complex array of regulators. Immunostaining is now a commonly applied technique to identify these numerous cell types and regulators in lesions. The principle of the technique is that an antibody is incubated with the tissue under conditions that favor a specific interaction with its antigen. This is subsequently visualized most commonly by a chromogenic substrate that produces a colored precipitate at the location of the antigen-antibody interaction. When appropriately applied, it is a powerful technique to provide mechanistic insight into the atherogenic process. However, the complexity of atherosclerotic tissue can provide challenges to ensuring that development of the chromogen is due to specific antigen-antibody interaction. Thus, the determination of specific interactions frequently requires the judicious use of appropriate control experiments.
UR - http://www.scopus.com/inward/record.url?scp=40549085741&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=40549085741&partnerID=8YFLogxK
U2 - 10.1007/978-1-59745-571-8_4
DO - 10.1007/978-1-59745-571-8_4
M3 - Article
C2 - 18287665
AN - SCOPUS:40549085741
SN - 1543-1894
VL - 139
SP - 77
EP - 94
JO - Methods in molecular medicine
JF - Methods in molecular medicine
ER -